Irritable bowel disease, which is defined as chronic idiopathic inflammation of the digestive tract, affects 3.1 million adults in the United States.
Geoffrey Brown, PharmD Candidate
Advertisement
Articles by Geoffrey Brown, PharmD Candidate
Advertisement
Latest Updated Articles
Pharmacologic Treatment Challenges for IBDPublished: February 27th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
KEYNOTE Trial Data Presented at ESMO 2025 Congress Reiterate Pembrolizumab’s Benefits in NSCLC
3
Court Ruling Highlights Risks of Improper Dose Adjustments
4
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
5
